source
- AI drug repurposing in oncology hampered by fragmented data, curated knowledge neededAI tools are being used to look for new cancer indications for existing biologics, but the article notes that fragmented and disparate data sets limit even the most advanced models. Repurposing pr…
- Vertex halts mRNA cystic fibrosis program citing tolerability concernsVertex Pharmaceuticals announced it is ending development of its mRNA-based cystic fibrosis therapy after encountering tolerability problems that echo challenges seen elsewhere in the field. The B…